Femtech Market by Offering, Application, End-Use

List of Tables

[185 Pages Report] The Femtech Market size was estimated at USD 35.91 billion in 2023 and expected to reach USD 40.85 billion in 2024, at a CAGR 14.47% to reach USD 92.51 billion by 2030.

Global Femtech Market

KEY MARKET STATISTICS
Base Year [2023]	USD 35.91 billion
Estimated Year [2024]	USD 40.85 billion
Forecast Year [2030]	USD 92.51 billion
CAGR (%)	14.47%

Femtech focuses on addressing the needs of U.S. women from a technological standpoint and encompasses several products and services developed to improve women's health and safety. These include products related to fertility tracking, contraception, maternal health, sexual wellness, mental health, work-life balance, and financial security, among others. Femtech is quickly becoming an important part of the U.S. healthcare landscape as it seeks to improve women's health with innovative solutions tailored to their unique needs and preferences. As women's healthcare enables better outcomes for society, female patients, consumers, and other stakeholders across the value chain, the demand for fintech is rapidly increasing. The high percentage of working women and the growing federal government focus on enhancing women's health drives the usage of femtech products and services in the United States. On the contrary, the lack of support from emerging U.S. countries for women's health and cybersecurity concerns hinders market growth. However, the development of novel femtech products and services, the rising number of consumer-centric startups, and the increasing availability of customized products are expected to accelerate their usage in the coming years in the United States.

Regional Insights

The femtech market in the Americas region is evolving due to women's high integration of femtech products & services, a large share of market players in North America, the gradual adoption of femtech products, and the emergence of new startups in South America. Telemedicine platforms provide more accessible and affordable healthcare solutions for U.S. women, specifically in rural areas with limited access to specialized care providers. Artificial intelligence (AI) and efficient data analytics are also playing an increasingly important role in femtech product development in the country. AI-driven algorithms can help predict fertility windows, monitor hormonal cycles, and offer personalized insights into U.S. women's health issues based on their unique physiological data. The rise in female entrepreneurship is another notable trend as more women-founded startups enter the femtech market in the United States with innovative ideas focused on addressing unmet female healthcare needs. This growing representation of female entrepreneurs ensures that products are designed with U.S. women's perspectives in mind and also promotes gender equality within the technology sector. Thus, these key trends indicate a promising future for femtech within the United States as technological advancements prioritize and address women-specific health issues through improved accessibility, data-driven personalization, telehealth services, and increased representation of female entrepreneurs.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Femtech Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Femtech Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Femtech Market, highlighting leading vendors and their innovative profiles. These include Allara Health, Apple Inc., Athena Feminine Technologies, Inc., AVA Sciences-FMTC LLC, Bloomlife, Canopie Inc., Caraway, Inc., Carrot Fertility, Inc., Chiaro Technology Limited, Chorus Health Inc., Cleo Labs, Inc., Clue by Biowink GmbH, Elektra Health, Everlywell, Inc., Fitbit LLC by Google, Inc., Flo Health UK Limited, FOLX Health, Inc., Future Family, Inc., Garmin Ltd., Glow Inc., INTIMINA, Kindbody, Koninklijke Philips N.V., Maven Clinic Co., NextGen Jane, Nuvo Group Ltd., Organon & Co., Renovia Inc., Rosy Wellness, Inc., Rume Medical Group, Inc., Samsung Electronics Co., Ltd., Thirty Madison company, Tia, Inc., Unified Women's Healthcare, Univfy Inc., Willow Innovations, Inc., and Wolomi.

Market Segmentation & Coverage

This research report categorizes the Femtech Market to forecast the revenues and analyze trends in each of the following sub-markets:

Offering
- Products
  - Consumer Products
  - Home Testing Kits
  - Trackers & Wearables
- Services
  - Benefits & Financing
  - Clinical Diagnostics
  - Patient Support
  - Virtual Care
- Software
  - Fertility Management & Assisted Reproductive Technology Apps
  - Fitness Trackers
Application
- Fitness & Nutrition
- General Health
- Gynecology & Sexual Health
  - Menopause
  - Menstrual Health
  - Pregnancy & Postpartum Care
- Mental Health
End-Use
- Personal
- Professional
  - Diagnostic Centers
  - Fertility Clinics
  - Hospitals
Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Femtech Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Femtech Market?

3. What are the technology trends and regulatory frameworks in the Femtech Market?

4. What is the market share of the leading vendors in the Femtech Market?

5. Which modes and strategic moves are suitable for entering the Femtech Market?

Product Code: MRR-8C74ADFC0419

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Femtech Market, by Region

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Rising need to manage the better health of working women in the U.S.
  - 5.1.1.2. Rising government initiatives and investments towards improving healthcare quality for women
- 5.1.2. Restraints
  - 5.1.2.1. Lack of standardized data and limited public support
- 5.1.3. Opportunities
  - 5.1.3.1. Technological advancements and introduction of innovative femtech products
  - 5.1.3.2. Surging number of startups for women healthcare management
- 5.1.4. Challenges
  - 5.1.4.1. Data security and privacy concerns associated with femtech products
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter's Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Femtech Market, by Offering

6.1. Introduction
6.2. Products
- 6.3.1. Consumer Products
- 6.3.2. Home Testing Kits
- 6.3.3. Trackers & Wearables
6.3. Services
- 6.4.1. Benefits & Financing
- 6.4.2. Clinical Diagnostics
- 6.4.3. Patient Support
- 6.4.4. Virtual Care
6.4. Software
- 6.5.1. Fertility Management & Assisted Reproductive Technology Apps
- 6.5.2. Fitness Trackers

7. Femtech Market, by Application

7.1. Introduction
7.2. Fitness & Nutrition
7.3. General Health
7.4. Gynecology & Sexual Health
- 7.5.1. Menopause
- 7.5.2. Menstrual Health
- 7.5.3. Pregnancy & Postpartum Care
7.5. Mental Health

8. Femtech Market, by End-Use

8.1. Introduction
8.2. Personal
8.3. Professional
- 8.4.1. Diagnostic Centers
- 8.4.2. Fertility Clinics
- 8.4.3. Hospitals

9. Americas Femtech Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Femtech Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Femtech Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
- 12.3.1. Merger & Acquisition
  - 12.3.1.1. Unified Women's Healthcare Acquires Menopause Care Delivery Platform Gennev
- 12.3.2. Agreement, Collaboration, & Partnership
  - 12.3.2.1. Maternal health data platform eLovu Health partners with Caduceus
  - 12.3.2.2. Samsung and Natural Cycles Partner to Bring Advanced Temperature-Based Cycle Tracking to Galaxy Watch5 Series
  - 12.3.2.3. Health Transformation Alliance Teams up with Carrot Fertility to Expand Access To Family-Building Benefits
- 12.3.3. New Product Launch & Enhancement
  - 12.3.3.1. NEWSOrganon launches US$30m initiative to reduce unplanned pregnancies
  - 12.3.3.2. California-based company unveils 'smart' ring for women
  - 12.3.3.3. Caraway Launches Virtual Healthcare Services for Women+ at Colleges Across the United States
- 12.3.4. Investment & Funding
  - 12.3.4.1. Herself Health Lands USD 26 Million As Femtech Startup Funding Holds Steady
  - 12.3.4.2. Rosy Wellness Raises USD 1.2 Million To Grow Its Women's Sexual Health Platform
  - 12.3.4.3. Reproductive health app Clue scores Euro 7 million
  - 12.3.4.4. Women's health startup Iron Health launched with USD 4.5 million
  - 12.3.4.5. Kindbody Announces USD 100 Million in New Funding to Further Accelerate Growth
  - 12.3.4.6. US start-up lands USD 25 million investment for female incontinence digital treatment
  - 12.3.4.7. Future Family raises USD 25 million for fertility financing

13. Competitive Portfolio

13.1. Key Company Profiles
- 13.1.1. Allara Health
- 13.1.2. Apple Inc.
- 13.1.3. Athena Feminine Technologies, Inc.
- 13.1.4. AVA Sciences-FMTC LLC
- 13.1.5. Bloomlife
- 13.1.6. Canopie Inc.
- 13.1.7. Caraway, Inc.
- 13.1.8. Carrot Fertility, Inc.
- 13.1.9. Chiaro Technology Limited
- 13.1.10. Chorus Health Inc.
- 13.1.11. Cleo Labs, Inc.
- 13.1.12. Clue by Biowink GmbH
- 13.1.13. Elektra Health
- 13.1.14. Everlywell, Inc.
- 13.1.15. Fitbit LLC by Google, Inc.
- 13.1.16. Flo Health UK Limited
- 13.1.17. FOLX Health, Inc.
- 13.1.18. Future Family, Inc.
- 13.1.19. Garmin Ltd.
- 13.1.20. Glow Inc.
- 13.1.21. INTIMINA
- 13.1.22. Kindbody
- 13.1.23. Koninklijke Philips N.V.
- 13.1.24. Maven Clinic Co.
- 13.1.25. NextGen Jane
- 13.1.26. Nuvo Group Ltd.
- 13.1.27. Organon & Co.
- 13.1.28. Renovia Inc.
- 13.1.29. Rosy Wellness, Inc.
- 13.1.30. Rume Medical Group, Inc.
- 13.1.31. Samsung Electronics Co., Ltd.
- 13.1.32. Thirty Madison company
- 13.1.33. Tia, Inc.
- 13.1.34. Unified Women's Healthcare
- 13.1.35. Univfy Inc.
- 13.1.36. Willow Innovations, Inc.
- 13.1.37. Wolomi
13.2. Key Product Portfolio

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing